“Our jury was very impressed by the CEOs and their presentations, which made picking ten highly promising startups across five industry clusters all the more challenging“, says Carmen Lamparter, COO of the W.A. de Vigier Foundation.
From over 200 submitted projects, the jury picked their Top 16 in February. The 16 CEOs went through an interview process and presented their ideas to the Foundation Board, who now chose the final ten nominees.
Full article here.
diaxxoPod (RUO)
Our in-vitro diagnostic test cartridge based on rapid Polymerase Chain Reaction (PCR) amplification technology. This cartridge can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage).
The test cartridge is aimed to improve the public health situation by rapidly enabling the detection of variants of concern. The cartridge is designed for qualitative detection of variants of interest of the SARS-CoV-2 Viral RNA in saliva samples and it works in conjuction with diaxxoPCR.
The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:
diaxxoPod
The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
